News

< Back

Grantee in the News: Arti Hurria interviewed on providing optimal care for older breast cancer patients by Medscape.com

On April 7, 2017, Arti Hurria, MD, a 2005 Beeson Scholar, was interviewed on Medscape on how to best meet the needs of older patients diagnosed with breast cancer.

Dr. Hurria emphasizes the importance of providing patients with individualized care based their geriatric assessment and functional age, and then utilizing that information as part of the treatment decision-making process. She advocates for older patients and their doctors to use an online geriatric assessment tool found on the Cancer and Aging Research Group website for appointment speed and efficiency.

Dr. Hurria also discusses her research finding that age (72 years old and older) is a predictor for chemotherapy-associated toxicity. She also found that gastrointestinal and genitourinary cancers and tumor and treatment variables were predicted risks for toxicity.

The full article and video are available with a free subscription to Medscape.com here.

Arti Hurria, MD is a professor of medical oncology and director of the Cancer and Aging Research Program at the City of Hope Comprehensive Cancer Center.


For a greater understanding of breast cancer, reviewed AFAR’s expert-edited Infoaging Guide to Breast Cancer.

More Recent News

View All News >
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Norman Volk, Former AFAR Board Member
In Memoriam: Norman Volk, Former AFAR Board Member
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors